Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Prostate Adenocarcinoma × enzalutamide × Clear all

Sponsor

Conditions

Prostatic Neoplasms 67 Breast Neoplasms 9 Neoplasm Metastasis 7 Prostatic Neoplasms, Castration-Resistant 6 Neoplasms 5 Metastatic Castration-resistant Prostate Cancer 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Prostate Cancer Metastatic 3 Metastatic Castration Resistant Prostate Cancer 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Metastatic Hormone Sensitive Prostate Cancer 2 Melanoma 2 Bulbo-Spinal Atrophy, X-Linked 2 mCRPC 1 Urinary Bladder Diseases 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Ureteral Diseases 1 Solid Tumours 1 Small Cell Lung Carcinoma 1 Seizures 1 Salivary Cancer 1 Recurrent Endometrial Endometrioid Adenocarcinoma 1 Pancreatic Neoplasms 1 Non-metastatic, Hormone naïve Prostate Cancer 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms, Squamous Cell 1 Metastatic Progressive Castration-resistant Prostate Cancer 1

Interventions

luprolide acetate gel depot 2 Leuprolide 2 Goserelin 2 radium Ra 223 dichloride 1 niraparib 1 apalutamide 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 Watchful Waiting 1 Triptorelin Pamoate 1 Receptors, Bombesin 1 Radiotherapy 1 Radiosurgery 1 Radiation Dose Hypofractionation 1 Radiation 1 Observation 1 Neoadjuvant Therapy 1 Methods 1 Magnetic Resonance Spectroscopy 1 Gallium 1 Educational Status 1 Early Intervention, Educational 1 Counseling 1 Cholecalciferol 1 BAY 86-7548 1 Adjuvants, Pharmaceutic 1 68Ga-bombesin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡